Autophagic Cell Death of Human Pancreatic Tumor Cells Mediated by Oleandrin, a Lipid-Soluble Cardiac Glycoside

Autor: Yasuko Kondo, Robert A. Newman, Diana Chan, Susan Dixon, Peiying Yang, Carrie Cartwright, Mary Johansen, Tomohisa Yokoyama
Rok vydání: 2007
Předmět:
0301 basic medicine
Oleandrin
Programmed cell death
Blotting
Western

Cell
Antineoplastic Agents
Biology
Transfection
Cardiac Glycosides
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Microscopy
Electron
Transmission

Cell Line
Tumor

Autophagy
medicine
Humans
Organic Chemicals
Phosphorylation
Extracellular Signal-Regulated MAP Kinases
Protein Kinase Inhibitors
Cell Proliferation
Cardiac glycoside
Dose-Response Relationship
Drug

Molecular Structure
Cell growth
Cell Cycle
Cell cycle
Lipids
Mitochondria
Cell biology
Pancreatic Neoplasms
Cardenolides
030104 developmental biology
medicine.anatomical_structure
Solubility
Complementary and alternative medicine
Oncology
chemistry
Apoptosis
030220 oncology & carcinogenesis
Microtubule-Associated Proteins
Proto-Oncogene Proteins c-akt
Signal Transduction
medicine.drug
Zdroj: Integrative Cancer Therapies. 6:354-364
ISSN: 1552-695X
1534-7354
DOI: 10.1177/1534735407309623
Popis: Lipid-soluble cardiac glycosides such as bufalin, oleandrin, and digitoxin have been suggested as potent agents that might be useful as anticancer agents. Past research with oleandrin, a principle cardiac glycoside in Nerium oleander L. (Apocynaceae), has been shown to induce cell death through induction of apoptosis. In PANC-1 cells, a human pancreatic cancer cell line, cell death occurs not through apoptosis but rather through autophagy. Oleandrin at low nanomolar concentrations potently inhibited cell proliferation associated with induction of a profound G2/M cell cycle arrest. Inhibition of cell cycle was not accompanied by any significant sub G1 accumulation of cells, suggesting a nonapoptotic mechanism. Oleandrin-treated cells exhibited time- and concentration-dependent staining with acridine orange, a lysosomal stain. Subcellular changes within PANC-1 cells included mitochondrial condensation and translocation to a perinuclear position accompanied by vacuoles. Use of a fluorescent oleandrin analog (BODIPY-oleandrin) revealed co-localization of the drug within cell mitochondria. Damaged mitochondria were found within autophagosome structures. Formation of autophagosomes was confirmed through electron microscopy and detection of green fluorescent protein—labeled light chain 3 association with autophagosome membranes. Also observed was a drug-mediated inhibition of pAkt formation and up-regulation of pERK. Transfection of Akt into PANC-1 cells or inhibition of pERK activation by MAPK inhibitor abrogated oleandrin-mediated inhibition of cell growth, suggesting that the reduction of pAkt and increased pERK are important to oleandrin's ability to inhibit tumor cell proliferation. The data provide insight into the mechanisms and role of a potent, lipid-soluble cardiac glycoside (oleandrin) in control of human pancreatic cancer proliferation.
Databáze: OpenAIRE